Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Clinical trial NCT00136396 · COMPLETED
Trial details
- NCT number
- NCT00136396
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2006-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.